Seghatchian J
Blood Component Technology & Haemostases/Thrombosis Consultancy, London, UK.
Dev Biol (Basel). 2002;108:129-36.
The 21 presentations have been arranged into two broad inter-related groups: (i) Quality of therapeutic preparations and studies on viral/bacterial inactivation procedures. (ii) Diagnostic assays for viral safety and quality control of blood components. Furthermore, in line with the main theme of this symposium, I have attempted to provide an overview of pertinent continuing investigation of blood component safety and supply, the "twin pillars" of transfusion therapy, focusing on the three pointers (3Ps) of the quality system-patient, process and product.
这21个报告已被分为两个广泛且相互关联的组：（i）治疗制剂的质量以及病毒/细菌灭活程序的研究。（ii）血液成分病毒安全性的诊断检测及质量控制。此外，根据本次研讨会的主题，我试图概述输血治疗的“两大支柱”——血液成分安全性和供应方面的相关持续研究，重点关注质量体系的三个要点，即患者、流程和产品。
